Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

The company plans to use the Series B investment to advance the development of its macrophage therapies in inflammatory and ...

Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX-001, in the treatment of end-stage liver disease and has raised £63.5 million ...

B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Cynthia Butler’s anger evolved into activism after Amanda Lane died at the Mabel Bassett Correctional Center in February 2022 ...

BHUBANESWAR: Ananta Mahakud had always envisioned a bright future for his only daughter Truptimayee. His dreams came crashing ...

We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, we are going to take a look ...

Several of the new FCEVs are anticipated to support J.B. Hunt Intermodal operations in California and will primarily be used ...

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara ...

Find out about Resolution Therapeutics' macrophage therapy, as it just raised $85 million in a series B round.

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...